Levicept is focused on developing innovative solutions for managing chronic pain, particularly in patients suffering from osteoarthritis. The company aims to provide effective analgesia that minimizes the risks associated with prolonged opioid use and the adverse effects commonly linked to non-steroidal anti-inflammatory drugs (NSAIDs). By prioritizing patient safety and comfort, Levicept is committed to transforming the lives of individuals enduring chronic pain through its advanced therapeutic approaches.

The company’s pipeline includes a range of products designed to address the complexities of pain management. Levicept leverages cutting-edge scientific research to create therapies that are not only effective but also well-tolerated by patients. This focus on developing safer alternatives to traditional pain relief methods underscores Levicept's mission to enhance the quality of life for those affected by chronic pain conditions.

United Kingdom

Levicept Ltd is a UK-based biotechnology company developing a novel, safe and efficacious biological therapy (LEVI-04 [p75NTR-Fc]) for the treatment of chronic pain. LEVI-04 is currently in a phase II study in patients with osteoarthritis of the knee.

Levicept

Company Details